APPLIED DNA SCIENCES, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.317 USD | -3.94% |
|
-7.78% | -48.52% |
Presentation Operator MessageOperator (Operator)Good evening, and welcome to the Applied DNA S...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Applied DNA Sciences, Inc. is a biotechnology company that develops, and markets deoxyribonucleic acid (DNA) based technology solutions. The Company is utilizing its LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform. The Companyâs proprietary platform produces large quantities of DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets and for supply chain security, anti-counterfeiting and anti-theft technology purposes. It also develops PCR-based molecular in vitro diagnostics for covid-19. In addition, under its wholly owned subsidiary, Applied DNA Clinical Labs, LLC, the Company is offering a high-throughput turnkey solution for population-scale Covid-19 testing marketed as safeCircle. safeCircle utilizes the Companyâs Covid-19 Diagnostic Tests and is designed to look for infection within defined populations or communities utilizing high throughput testing methodologies.
Calendar
2024-05-08
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
0.33
USD
Average target price
2.25
USD
Spread / Average Target
+581.82%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -48.52% | 5.6M | |
| +0.89% | 12.66B | |
| -17.03% | 7.04B | |
| +2.25% | 5.39B | |
| -1.37% | 4.45B | |
| +3.48% | 4.32B | |
| -48.52% | 3.31B | |
| +6.90% | 2.6B | |
| -15.56% | 2.01B | |
| -1.96% | 1.67B |
- Stock Market
- Equities
- APDN Stock
- News Applied DNA Sciences, Inc.
- Transcript : Applied DNA Sciences, Inc., Q2 2022 Earnings Call, May 12, 2022
